Abstract
Exposure to subinhibitory concentrations (4–8 µg/ml) of azithromycin resulted in loss of motility inProteus mirabilis strains and a significant reduction of motility inPseudomonas aeruginosa strains. Examination revealed that the loss of motility was due to a total absence of flagella inProteus mirabilis while the poor motility observed inPseudomonas aeruginosa was due to absence of flagella in the majority of the population. Since motility may be considered a pathogenicity trait in the two species, these results confirm the unusual ability of azithromycin to reduce the expression of virulence factors in gram-negative pathogens.
Similar content being viewed by others
References
Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 1990, 25, Supplement A: 73–82.
Neu HC, Chin NX, Saha G, Labthavikul P: Comparative in vitro activity of the new oral macrolide azithromycin. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 541–544.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically. Approved Standard M7-A, NCCLS, Villanova, PA, 1985.
Kodaka H, Armfield AY, Lombard GL, Dowel VR: Practical procedure for demonstrating bacterial flagela. Journal of Clinical Microbiology 1982, 16: 948–952.
Craven RC, Montie TC: Motility and chemotaxis of three strains ofPseudomonas aeruginosa used for virulence studies. Canadian Journal of Microbiology 1981, 27: 458–460.
Montie TC, Doyle-Huntzinger D, Craven RC, Holder IA: Loss of virulence associated with absence of flagellum in an isogenic mutant ofPseudomonas aeruginosa in the burned-mouse model. Infection and Immunity 1982, 38: 1296–1298.
Pollack M: The virulence ofPseudomonas aeruginosa. Reviews of Infectious Diseases 1984, 6, Supplement 3: 617–626.
Ochi H, Ohtsuka H, Yokota SI, Uezumi I, Terashima M, Irie K, Noguchi H: Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella ofPseudomonas aeruginosa. Infection and Immunity 1991, 59: 550–554.
Holder I, Wheeler R, Montie TC: Flagellar preparations fromPseudomonas aeruginosa: animal protection studies. Infection and Immunity 1982, 35: 276–280.
Drake D, Montie TC: Protection againstPseudomonas aeruginosa infection by passive transfer of anti-flagellar serum. Canadian Journal of Microbiology 1987, 33: 755–763.
Drake D, Montie TC: Flagella, motility and invasive virulence ofPseudomonas aeruginosa. Journal of General Microbiology 1988, 134: 43–52.
Pazin GJ, Braude AI: Immobilizing antibodies in urine. II: Prevention of ascending spread ofProteus mirabilis. Investigative Urology 1974, 12: 129–133.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molinari, G., Paglia, P. & Schito, G.C. Inhibition of motility ofPseudomonas aeruginosa andProteus mirabilis by subinhibitory concentrations of azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 11, 469–471 (1992). https://doi.org/10.1007/BF01961867
Issue Date:
DOI: https://doi.org/10.1007/BF01961867